Iontophoresis, the use of an electric current to drive charged molecul
es across the skin, has the potential to expand the feasible range of
drugs for transdermal administration significantly, This method of del
ivery is being examined carefully with respect to higher-molecular-wei
ght therapeutics (in particular, peptides and small proteins), which c
annot be absorbed following oral administration and for which, at this
time, an invasive injection remains the only option, In addition, the
procedure of so-called 'reverse' iontophoresis would appear to repres
ent a truly noninvasive approach for diagnostic monitoring of blood ch
emistry.